Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 2/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KCNN4 | O15554 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2119823 | 0.79 | ALDH1A1 (0.38) | ALDH1A1LMNAMAPK1TSHRALOX12 | |
| SCHEMBL1925168 | 0.69 | ALDH1A1 (0.43) | ALDH1A1LMNATSHRCYP3A4ALOX15 | |
| SCHEMBL1899890 | 0.67 | ALDH1A1 (0.43) | ALDH1A1LMNATSHRALOX12ACHE | |
| SCHEMBL49458 | 0.67 | — | — | |
| SCHEMBL451030 | 0.65 | ALDH1A1 (0.47) | ALDH1A1LMNATSHRALOX12ACHE | |
| SCHEMBL3887567 | 0.65 | — | — | |
| SCHEMBL6850 | 0.62 | MAPK1 (0.50) | ALDH1A1MAPK1TSHRTAAR1CYP3A4 | |
| SCHEMBL13042644 | 0.62 | — | — | |
| SCHEMBL6247502 | 0.62 | — | — | |
| SCHEMBL11649729 | 0.61 | CYP3A4 (0.45) | ALDH1A1LMNAMAPK1TSHRALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117835718-A | White light organic electroluminescent composition and application thereof | 深圳大学 | 2024-04-05 | — | — | CN | claimed |
| CN-117835718-A | White light organic electroluminescent composition and application thereof | 深圳大学 | 2024-04-05 | — | — | CN | disclosed |
| US-7622201-B2 | Pyrene compound and organic light emitting device | CANON KABUSHIKI KAISHA (JP) | 2009-11-24 | — | — | US | disclosed |
| US-20090200935-A1 | PYRENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2009-08-13 | — | — | US | disclosed |
| US-7538250-B2 | Pyrene compound and organic light emitting device | CANON KABUSHIKI KAISHA (JP) | 2009-05-26 | — | — | US | disclosed |
| US-20080119671-A1 | PYRENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2008-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119671-A1 | PYRENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | AHR, CYP1A1, ARNT | ALDH1A1 604/4885LMNA 1122/4885MAPK1 2652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.